1. It‘s a Variant of Unknown Significance. Management of the breast in VUS carriers is not the same as those with known pathogenic mutations.
2. Are current margins clear? If current margins are now negative, I would proceed with postoperative radiotherapy of the breast. If margins are still positive, it depends on how good BCS can be attempted again. If cosmesis is going to bad after a third surgery, then mastectomy should be offered.
To all who advocate for mastectomy now, regardless of cosmesis: If you recommend mastectomy for the affected breast, you should recommend it for the other breast too (+/- ovaries, I think BRCA2 bears lower risk than BRCA1, but correct me if I am wrong). The risk of contralateral breast cancer in a patient with a known pathogenic BRCA mutation is higher than the risk of ipsilateral breast cancer recurrence following BCS+RT.